ashish shah, md
University of Miami · University of Alabama at Birmingham
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name ashish shah, md as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:18 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06428045 · STARLITE for Unresectable High-Grade GliomasUniversity of Miami · recruiting · High Grade Glioma · principal investigator
- Ph2NCT06264388 · DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic AstrocytomaAshish Shah · recruiting · High Grade Glioma, Anaplastic Astrocytoma · principal investigator
- N/ANCT03780452 · Compression Nail for Tibiocalcaneal ArthrodesisUniversity of Alabama at Birmingham · completed · Subtalar Arthritis, Ankle Arthritis · principal investigator
- N/ANCT03522753 · Staple Versus Suture Closure for Foot and Ankle SurgeryUniversity of Alabama at Birmingham · withdrawn · Incision, Foot Ankle Injuries · principal investigator
- Ph4NCT03401749 · Preadmission Skin Wipe Use for Surgical Site Infection Prophylaxis in Adult Orthopaedic Surgery PatientsUniversity of Alabama at Birmingham · terminated · Surgical Site Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic AstrocytomaR21CA282543 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Ashish Harish Shah, Macarena I de la Fuente · fiscal years 2023 to 2024Named on NCT06264388
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.